Lazard Asset Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-97,022
Closed -$6.55M 1951
2025
Q3
$6.55M Sell
97,022
-1,551
-2% -$103K 0.01% 512
2025
Q2
$6.42M Sell
98,573
-135
-0.1% -$8.09K 0.01% 663
2025
Q1
$6.1M Buy
98,708
+8,477
+9% +$562K 0.01% 622
2024
Q4
$6.5M Sell
90,231
-3,450
-4% -$270K 0.01% 571
2024
Q3
$7.63M Sell
93,681
-11,654
-11% -$932K 0.01% 529
2024
Q2
$7.82M Sell
105,335
-398
-0.4% -$29.8K 0.01% 566
2024
Q1
$8.24M Sell
105,733
-982
-0.9% -$73.1K 0.01% 587
2023
Q4
$7.62M Sell
106,715
-3,777
-3% -$263K 0.01% 608
2023
Q3
$7.67M Sell
110,492
-124,111
-53% -$9.38M 0.01% 608
2023
Q2
$19M Buy
234,603
+63,673
+37% +$5.2M 0.02% 415
2023
Q1
$13.8M Buy
170,930
+3,355
+2% +$270K 0.02% 520
2022
Q4
$12.5M Sell
167,575
-157,463
-48% -$11.2M 0.02% 528
2022
Q3
$21M Buy
325,038
+18,136
+6% +$1.26M 0.03% 399
2022
Q2
$21.3M Buy
306,902
+170,996
+126% +$12.7M 0.03% 413
2022
Q1
$10.4M Buy
135,906
+52,827
+64% +$3.8M 0.01% 598
2021
Q4
$6.36M Buy
83,079
+8,312
+11% +$611K 0.01% 729
2021
Q3
$5.52M Buy
74,767
+27,220
+57% +$2.04M 0.01% 739
2021
Q2
$3.17M Sell
47,547
-172,843
-78% -$11.6M ﹤0.01% 791
2021
Q1
$16.4M Buy
220,390
+161,242
+273% +$12.2M 0.02% 465
2020
Q4
$4.31M Sell
59,148
-15,154
-20% -$1.07M 0.01% 682
2020
Q3
$4.94M Buy
74,302
+36,832
+98% +$2.33M 0.01% 608
2020
Q2
$2.13M Buy
37,470
+4,223
+13% +$207K ﹤0.01% 673
2020
Q1
$1.17M Buy
33,247
+32,269
+3,299% +$1.54M ﹤0.01% 726
2019
Q4
$51K Sell
978
-37,219
-97% -$1.85M ﹤0.01% 1052
2019
Q3
$1.93M Buy
+38,197
New +$1.88M ﹤0.01% 671

Other funds holding HOLX

Lazard Asset Management's HOLX Position: Q4 2025 in Review

Lazard Asset Management sold out of Hologic (HOLX) in Q4 2025, closing a stake of 97,022 shares — an estimated $6.55M sold.

Lazard Asset Management first reported a position in HOLX in Q3 2019 and held it in 25 quarters. The position peaked at $21.3M in Q2 2022. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

  • Lazard Asset Management reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
  • Lazard Asset Management sold 97,022 Hologic shares in Q4 2025, an estimated $6.55M.
  • Lazard Asset Management first reported a position in Hologic in Q3 2019 and held it in 25 quarters.
  • Lazard Asset Management's Hologic position peaked at $21.3M in Q2 2022.
  • 749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on Lazard Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.